Innovation, Jobs and Patents: Understanding the Connection

Brought to you by
ACS Science & the Congress Project
Honorary Co-Hosts
The House R&D Caucus
Co-Chairs Rep. Judy Biggert (R-IL) and Rep. Rush Holt (D-NJ)
Chairman Ben Quayle (R-AZ), Subcommittee on Technology & Innovation, House Science, Space and Technology Committee

This briefing will explore how U.S. intellectual property policy impacts the ability of U.S. science and technology innovators and entrepreneurs to compete and provide high-paying jobs. Our educational system and industrial companies have a long history of placing the United States as a world leader in intellectual property. The connection between this and American jobs has been seriously impacted by global competition and the economic downturn. To learn more about how intellectual property policy can play a role in creating and preserving jobs, particularly in light of pending patent reform legislation, join this event.

Video from June 8, 2011

Speaker Bios & Presentations

Teresa Stanek Rea, is the deputy under secretary of Commerce for Intellectual Property and the deputy director of the U.S. Patent and Trademark Office (USPTO). Ms. Rea joined the USPTO as deputy director in 2011, and in this role she oversees an office that encourages innovation and technological advancement and helps businesses protect their investments, promote their goods, and safeguard against deception in the marketplace. Ms. Rea is a leading attorney in the field of intellectual property with more than 25 years of legal experience. She is a past president of the American Intellectual Property Law Association and a member of many other technical and legal associations. She has been a frequent lecturer and publisher on patent topics including biotechnology, nanotechnology, licensing, technology transfer, patent practice, export control. and interferences.

Before joining the USPTO, Ms. Rea was a partner in Crowell & Moring LLP’s Washington, D.C., office, where she focused on intellectual property and dispute resolution related to pharmaceutical, biotechnology, and other life science issues. She has experience in drafting infringement and validity opinions, as well as experience in interference and licensing matters. Ms. Rea also worked for Ethyl Corporation from 1980 through 1984 and for Burns, Doane, Swecker & Mathis, a patent boutique firm in Alexandria, Virginia. Ms. Rea received a juris doctor degree from Wayne State University and a bachelor of science degree in pharmacy from the University of Michigan.

W. Bernard Carlson, Ph.D., is a professor at the University of Virginia, with appointments in the Department of Science, Technology, and Society (School of Engineering and Applied Science) and the History Department (College of Arts and Sciences). He coordinates the Engineering Business Minor at U.Va. and teaches a course on “Engineers as Entrepreneurs.” Dr. Carlson is an expert on the role of innovation in American history, specifically on how inventors, engineers, and managers used technology to create new systems and enterprises between 1875 and 1925. His publications include Innovation as a Social Process: Elihu Thomson and the Rise of General Electric, 1870-1900 (Cambridge University Press, 1991; paper 2002), as well as Technology in World History, 7 volumes (Oxford University Press, 2005). In 2008, Technology in World History was awarded the Sally Hacker Prize from the Society for the History of Technology. With support from the Sloan Foundation, he has completed a biography of another electrical inventor, Nikola Tesla, titled Ideal and Illusion: The Life and Inventions of Nikola Tesla, which should be published in 2012.

Dr. Carlson has served on the board of trustees of the National Inventors Hall of Fame. He is also currently serving as the executive secretary for the Society for the History of Technology. He received his Ph.D. in the history and sociology of science from the University of Pennsylvania in 1984 and did his postdoctoral work in business history at the Harvard Business School.

Matthew Gevaert, Ph.D., is the chief executive officer of KIYATEC Inc., a life sciences company commercializing advanced three-dimensional cell culture plastic ware and cell-based diagnostics. KIYATEC helps researchers better understand and predict complex behavior of cell and tissue systems in vitro by creating new opportunities for improving human health while reducing the time and cost associated with life science research, drug discovery, and personalized medicine. He also maintains current appointments as adjunct professor in the Clemson University Department of Bioengineering and as visiting professor in the Spiro Institute for Entreprenuerial Leadership, where he teaches graduate courses in technological and biomedical entrepreneurship. Dr. Gevaert led the commercialization of Clemson University’s biomedical and biotechnology intellectual property portfolio for nearly five years, where he worked with both entrepreneurial start-ups and large, industry-leading corporations. Dr. Gevaert currently serves as president of SCMedTech, the industry organization for the state of South Carolina’s medical device and technology companies.

Dr. Gevaert has held a variety of professional roles with 3M, Dow Chemical, and Merck, and has additional experience as sole proprietor of Edge Biomedical, a biomaterials consulting practice. He has a bachelor’s degree in Applied Chemistry from the University of Waterloo and a master’s and doctorate in bioengineering from Clemson University.

Paul Sharer, Esq., is a partner at Jones Day, where he counsels clients in the areas of intellectual property procurement and enforcement as well as structuring license and joint venture deals with a focus on technological developments in the life sciences and business methods. He advises emerging and expanding companies and multinational pharmaceutical, biotechnology, and financial market corporations in developing and maintaining strategic patent estates. He has obtained more than 800 patents for clients in a wide variety of technological arts including pharmaceuticals, medical devices and diagnostics, combination therapies, biotechnology, DNA and protein diagnostics, disease markers, nanotechnology, gene shuffling, small molecule drugs, drug delivery, financial services, coatings, organic chemistry, polymers, additives, active plant extracts, biodiagnostic tools, adjuvents, surfectants, consumer products, health care and personal care, and business methods.

Mr. Sharer has experience in all types of proceedings before the U.S. Patent Office, including re-exams, reissues, appeals, and interferences. He frequently works with clients to provide litigation avoidance counseling, and has conducted numerous IP due diligences for licensing, financial investment, prelitigation, and acquisition projects. He has been recognized by the prestigious Chambers & Partners as one of “America’s Leading Lawyers for Business” in 2005, 2006, and 2007. Mr. Sharer has a B.S. in chemical engineering from Drexel University and a J.D. from Widener University.

Related Information


Data Visualization Center
Director’s Forum Blog

U.S. Department of Commerce

National Research Council

Chemical & Engineering News (a publication of the American Chemical Society)